Xingqi Pharmaceutical Says No Adverse Effects Seen in Phase 1 Eye Drops Trial
Published on 05/30/2025 at 05:53 am EDT
MT Newswires

|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.79 CNY | +0.49% |
|
-1.85% | -15.86% |
| 06-30 | Shenyang Xingqi Pharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 100 million worth of its shares. | CI |
| 06-28 | Shenyang Xingqi Pharmaceutical Co.,Ltd. authorizes a Buyback Plan. | CI |
Published on 05/30/2025 at 05:53 am EDT

Select your edition
All financial news and data tailored to specific country editions